Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$547 | -$893 | -$2,106 | -$1,837 |
| Dep. & Amort. | $63 | $72 | $43 | $29 |
| Deferred Tax | -$1 | -$1 | -$15 | $30 |
| Stock-Based Comp. | $112 | $230 | $1,931 | $1,606 |
| Change in WC | -$90 | $30 | -$37 | -$62 |
| Other Non-Cash | $143 | $267 | -$67 | -$21 |
| Operating Cash Flow | -$320 | -$296 | -$252 | -$254 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$63 | -$41 | -$52 | -$57 |
| Net Acquisitions | -$5 | -$39 | $27 | -$12 |
| Inv. Purchases | $0 | $0 | -$4 | -$5 |
| Inv. Sales/Matur. | $5 | $0 | $0 | $0 |
| Other Inv. Act. | $1 | -$1 | -$38 | $0 |
| Investing Cash Flow | -$62 | -$81 | -$67 | -$73 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | -$1 |
| Stock Issued | $0 | $0 | $99 | $0 |
| Stock Repurch. | $0 | -$0 | $0 | -$25 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$1 | -$3 | $1,560 |
| Financing Cash Flow | -$2 | -$3 | $95 | $1,534 |
| Forex Effect | -$0 | -$1 | $1 | -$0 |
| Net Chg. in Cash | -$384 | -$380 | -$223 | $1,207 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $990 | $1,370 | $1,593 | $386 |
| End Cash | $606 | $990 | $1,370 | $1,593 |
| Free Cash Flow | -$382 | -$336 | -$304 | -$310 |